- Obstetrics and Gynecology
- Radiology, Nuclear Medicine and imaging
- Reproductive Medicine
- General Medicine
- Radiological and Ultrasound Technology
ABSTRACTObjectiveType‐III vasa previa (VP) is a rare form of VP, not necessarily associated with other placental or vascular anomalies, in which aberrant vessels run from the placenta to the amniotic membranes, near the internal cervical os, before returning to the placenta. Early diagnosis of Type‐III VP is important but technically challenging. The objective of this study was to gather the current available evidence on the perinatal diagnosis and outcome of Type‐III VP.MethodsA systematic review of the literature on the perinatal diagnosis of atypical Type‐III VP was carried out in PubMed, MEDLINE and EMBASE accordingto PRISMA guidelines from inception to March 2023. Data extraction and tabulation were performed by two operators and checked by a third senior author. The quality of the included studies was evaluated using the National Institutes of Health tool for the quality assessment of case‐series studies. Our local ultrasound database was searched for previously unreported recent cases. Characteristics of prenatally and postnatally diagnosed Type‐III VP, including clinical features and perinatal outcomes, were summarized using descriptive statistics.ResultsEighteen cases of Type‐III VP were included, of which 16 were diagnosed prenatally (14 cases were retrieved from 10 publications and two were unpublished cases from our center) and two were diagnosed postnatally (retrieved from two publications). All prenatal cases were diagnosed on transvaginal ultrasound at a mean gestational age of 29 weeks (median, 31 weeks; range, 19–38 weeks). Conception was achieved with in‐vitro fertilization in 4/16 (25.0%) cases. There were no prenatal symptoms in 15/18 (83.3%) cases, while in two (11.1%) cases there was vaginal bleeding and in one (5.6%) preterm labor occurred. In 15/18 (83.3%) cases, at least one placental abnormality was observed, including low‐lying insertion (9/17), succenturiate or accessory lobe (1/17), velamentous cord insertion (3/18) and marginal insertion (9/18). All prenatally diagnosed cases were liveborn and were delivered by Cesarean section before rupture of membranes at a median gestational age of 35 weeks (range, 32–38 weeks) without neonatal complications. Emergency Cesarean section was performed in 2/16 (12.5%) cases with a prenatal diagnosis and 1/2 (50.0%) cases with a postnatal diagnosis (P = 0.179). Among those with data available, an Apgar score of ≤ 7 was observed in the prenatally vs postnatally diagnosed group in 5/13 vs 1/1 cases, respectively, at the 1‐min evaluation and 3/13 vs 1/1 cases, respectively, at the 5‐min evaluation.ConclusionsThe prenatal diagnosis of Type‐III VP is challenging, with few cases reported in the literature; however, it is crucial for minimizing the risk of adverse outcome by enabling early‐term elective Cesarean delivery prior to rupture of membranes. Given that clinical manifestations and risk factors are non‐specific, and that Type‐III VP cannot be excluded when there is a normal cord insertion or a singular placental mass, systematic screening by transvaginal ultrasound in the general pregnant population is recommended, particularly in those with a low‐lying or morphologically abnormal placenta and those who conceived using assisted reproductive technology. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Need a simple solution for managing your BibTeX entries? Explore CiteDrive!
- Web-based, modern reference management
- Collaborate and share with fellow researchers
- Integration with Overleaf
- Comprehensive BibTeX/BibLaTeX support
- Save articles and websites directly from your browser
- Search for new articles from a database of tens of millions of references
Try out CiteDrive More from our Archive
-
DOI: 10.1002/ijgo.14948 2023
Identification of women and girls with iron deficiency in the reproductive years
Beth MacLean, Michelle Sholzberg, Angela C. Weyand, Jayne Lim, Grace Tang, Toby Richards
-
DOI: 10.1002/ijgo.14949 2023
Optimizing diagnosis and treatment of iron deficiency and iron deficiency anemia in women and girls of reproductive age: Clinical opinion
Michael Auerbach
-
DOI: 10.1002/ijgo.14946 2023
Contemporary evaluation of women and girls with abnormal uterine bleeding: <scp>FIGO</scp> Systems 1 and 2
Varsha Jain, Malcolm G. Munro, Hilary O. D. Critchley
-
DOI: 10.1002/ijgo.14944 2023
Iron deficiency, pregnancy, and neonatal development
Ricardo Ataide, Katherine Fielding, Sant‐Rayn Pasricha, Cavan Bennett
-
DOI: 10.1002/ijgo.14951 2023
The importance of iron deficiency in pregnancy on fetal, neonatal, and infant neurodevelopmental outcomes
Michael K. Georgieff
-
DOI: 10.1002/ijgo.14943 2023
Heavy menstrual bleeding, iron deficiency, and iron deficiency anemia: Framing the issue
Malcolm G. Munro
-
DOI: 10.1002/ijgo.14945 2023
Reflections on access to care for heavy menstrual bleeding: Past, present, and in times of the COVID‐19 pandemic
Claire Henry, Sara Filoche
-
DOI: 10.1055/s-0043-1770093 2023
Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
Luisa Gracio Ferreira Sartori, Bruno Monteiro Nunes, Daniela Farah, Leticia Maria de Oliveira, Claudia Cristina Takano Novoa, Marair Gracio Ferreira Sartori, Marcelo Cunio Machado Fonseca
-
DOI: 10.1111/aji.13755 2023
The function of decidua natural killer cells in physiology and pathology of pregnancy
Fangfang Jin, Wei Liu, Guan Cheng, Songchen Cai, Tailang Yin, Lianghui Diao
-
DOI: 10.1111/aji.13755 2023
The function of decidua natural killer cells in physiology and pathology of pregnancy
Fangfang Jin, Wei Liu, Guan Cheng, Songchen Cai, Tailang Yin, Lianghui Diao